Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment
Srijit Das, Norsham Juliana, Noor Anisah Abu Yazit, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1649-1649
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Periodontitis and Its Inflammatory Changes Linked to Various Systemic Diseases: A Review of Its Underlying Mechanisms
Ruchi Bhuyan, Sanat Kumar Bhuyan, Jatindra Nath Mohanty, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2659-2659
Open Access | Times Cited: 94
A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: from molecular interactions to potential therapeutic targets
Mina Alimohammadi, Payman Rahimzadeh, Ramin Khorrami, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155401-155401
Closed Access | Times Cited: 8
Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma
Hong Yan, Nan Jiang, M Kellis, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Inhibition of CDC27 O-GlcNAcylation coordinates the antitumor efficacy in multiple myeloma through the autophagy-lysosome pathway
Hao Wu, Rencai Qin, Weijie Li, et al.
Acta Pharmacologica Sinica (2025)
Open Access
Comprehensive bioinformatics analysis reveals key hub genes linked to prognosis in multiple myeloma with drug resistance
X.D. Chen, Y. Wu, Yongqing Li, et al.
Medicine (2025) Vol. 104, Iss. 10, pp. e41707-e41707
Open Access
Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma
Shamila D. Alipoor, Hong Chang
Cells (2023) Vol. 12, Iss. 7, pp. 1030-1030
Open Access | Times Cited: 11
Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis
Qing-Ming Wang, Guang‐Yu Lian, Su-Mei Sheng, et al.
Molecular Cancer Research (2023) Vol. 22, Iss. 2, pp. 125-136
Closed Access | Times Cited: 10
The Role of Epigenetics in the Development and Progression of Multiple Myeloma
Nor Hayati Ismail, Ali Mussa, Nur Atikah Zakaria, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2767-2767
Open Access | Times Cited: 14
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics
Mohamed Halaby Elbahoty, Bhavyasree Papineni, Rajeev S. Samant
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 6, pp. 829-842
Open Access | Times Cited: 2
Galectin-9 – ligand axis: an emerging therapeutic target for multiple myeloma
Rajib Shil, Norhan B. B. Mohammed, Charles J. Dimitroff
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Altered expression of long noncoding RNA MEG3 in the offspring of gestational diabetes mellitus induces impaired glucose tolerance in adulthood
Meng Meng Yang, Juan Wei, Li Xu, et al.
Acta Diabetologica (2023) Vol. 61, Iss. 1, pp. 79-90
Closed Access | Times Cited: 6
Discovery of imidazo[1,2-b]pyridazine-containing TAK1 kinase inhibitors with excellent activities against multiple myeloma
Desmond Akwata, Allison L. Kempen, Jones Lamptey, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 178-192
Open Access | Times Cited: 6
IL1B Polymorphism (rs1143634) and IL-1β Plasma Concentration as Predictors of Nutritional Disorders and Prognostic Factors in Multiple Myeloma Patients
Marcin Mazurek, Aneta Szudy‐Szczyrek, Iwona Homa‐Mlak, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1263-1263
Open Access | Times Cited: 1
Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma
Yu Feng, Jingcao Huang, Fangfang Wang, et al.
Life Sciences (2023) Vol. 333, pp. 122157-122157
Closed Access | Times Cited: 4
Exploring the mechanisms of drug-delivery by decorated ZnO nanoparticles through predictive ReaxFF molecular dynamics simulations
Cheherazade Trouki, Giovanni Barcaro, Susanna Monti
Nanoscale (2022) Vol. 14, Iss. 36, pp. 13123-13131
Open Access | Times Cited: 7
YY1-induced LncRNA-TUG1 elevates YOD1 to promote cell proliferation and inhibit bortezomib sensitivity in multiple myeloma
Qingqing Yin, Xianjuan Shen, Honglei Xu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 6, pp. 1161-1174
Closed Access | Times Cited: 3
Bispecific BCMA-CD3 Antibodies Block Multiple Myeloma Tumor Growth
Lijun Wu, Yanwei Huang, John Sienkiewicz, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2518-2518
Open Access | Times Cited: 5
Influence of diabetes mellitus on the biochemical parameters and outcomes of multiple myeloma
Zhengyue Dou, Bing Xia, Chaoyu Wang, et al.
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 2
A rare multiple myeloma complication as a spinal cord metastasis: A case report
Marah Mansour, Zeinab Haider, Lin Al Khiami, et al.
Clinical Case Reports (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 2
LAMP5 may promote MM progression by activating p38
Yan Chen, Tao Ma
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 2
Network pharmacology- and molecular docking-based investigation of the therapeutic potential and mechanism of daucosterol against multiple myeloma
Junquan Zeng, Quanying Luo, Xiaoping Wang, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 4, pp. 1006-1020
Open Access | Times Cited: 2
Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes
Fatih M. Uckun, Sanjive Qazi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9943-9943
Open Access | Times Cited: 2
m5C Regulator-mediated methylation modification clusters contribute to the immune microenvironment regulation of multiple myeloma
Hefei Ren, Chang Liu, Hongkun Wu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 4
SSBP1 is a novel prognostic marker and promotes disease progression via p38MAPK signaling pathway in multiple myeloma
Pingping Xiao, Jizhen Wang, Tingting Li, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 4, pp. 728-741
Closed Access
PHF19 before and post induction treatment possess favorable potency of reflecting treatment response to protease inhibitors, event-free survival, and overall survival in multiple myeloma patients
Hongyu An, Shiming Chen, Xin Zhang, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top